Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 9, 2017
Nitric oxide: A new possible biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failureRoberto Jorge Bonafede, Juan Pablo Calvo, Julia María Valeria Fausti, et al.
Pediatric Nephrology (Berlin, Germany)|April 17, 2003
Heat shock proteins HSP27 and HSP70 in unilateral obstructed kidneysPatricia Vallés, Facundo Jorro, Liliana Carrizo, et al.
Nutrients|February 11, 2023
Genomic or Non-Genomic? A Question about the Pleiotropic Roles of Vitamin D in Inflammatory-Based DiseasesMichael F Holick, Luciana Mazzei, Sebastián García Menéndez, et al.
Current Hypertension Reviews|January 26, 2026
Rosuvastatin Reduces Allostatic Overload due to Mechanical Strain: A New Finding on Vascular Remodeling Linked to Hypertension in Spontaneously Hypertensive RatsVirna Margarita Martin Gimenez, Federico García, Alejandro Gutierrez, et al.
Life Sciences|May 19, 2020
Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatmentVirna Margarita Martín Giménez, Felipe Inserra, Carlos D Tajer, et al.
Health Security|December 16, 2020
Association Between Vitamin D Deficiency and COVID-19 Incidence, Complications, and Mortality in 46 Countries: An Ecological StudyJavier Mariani, Virna Margarita Marín Giménez, Ivana Bergam, et al.
Pharmaceutics|January 21, 2023
Polymeric Nanomicelles Loaded with Anandamide and Their Renal Effects as a Therapeutic Alternative for Hypertension Treatment by Passive TargetingVirna Margarita Martín Giménez, Marcela Analía Moretton, Diego Andrés Chiappetta, et al.
Advances in Medical Sciences|January 3, 2021
Central nervous system, peripheral and hemodynamic effects of nanoformulated anandamide in hypertensionVirna Margarita Martín Giménez, Feres José Mocayar Marón, Sebastián García, et al.
World Journal of Experimental Medicine|January 12, 2026
Potential role of nanopharmacology in reducing neuroinflammation associated with hypertension and metabolic disordersVirna Margarita Martín Giménez, Sebastián García Menéndez, Raúl Lelio Sanz, et al.
Biochemical Pharmacology|August 19, 2022
Physiopathological mechanisms involved in the development of hypertension associated with gut dysbiosis and the effect of nutritional/pharmacological interventionsVirna Margarita Martín Giménez, Natalia Lucía Rukavina Mikusic, Hyun Jin Lee, et al.
Pageof 11